Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients with Advanced Soft Tissue Sarcomas: The ANNOUNCE Randomized Clinical Trial

William D. Tap, Andrew J. Wagner, Patrick Schöffski, Javier Martin-Broto, Anders Krarup-Hansen, Kristen N. Ganjoo, Chueh Chuan Yen, Albiruni R. Abdul Razak, Alexander Spira, Akira Kawai, Axel Le Cesne, Brian A. Van Tine, Yoichi Naito, Se Hoon Park, Alexander Fedenko, Zsuzsanna Pápai, Victoria Soldatenkova, Ashwin Shahir, Gary Mo, Jennifer WrightRobin L. Jones

Research output: Contribution to journalArticlepeer-review

186 Scopus citations

Fingerprint

Dive into the research topics of 'Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients with Advanced Soft Tissue Sarcomas: The ANNOUNCE Randomized Clinical Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences